Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Fulgent Genetics is a leading US-based company in genetic testing and precision medicine, providing comprehensive diagnostic solutions for healthcare. Through innovative technologies, Fulgent enables personalized treatment and improves patient outcomes globally with its advanced genomic services.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Fulgent Genetics is scheduled to report its next quarterly earnings on 11/06/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Fulgent Genetics last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.58 USD.
Across its last 3 earnings reports, Fulgent Genetics stock moved by ±15.7% on average the following day. The largest reaction was -38.1% on 02/27/2026; 0 of 3 reactions were positive.
Fulgent Genetics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.